Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2023-11-09 Major Shareholding Noti…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
SC 13D
Major Shareholding Notification
2023-11-09 English
DIRECTOR DECLARATION
Foreign Filer Report
2023-11-09 English
IMFINZI COMBINATION IMPROVES PFS IN LIVER CANCER
Foreign Filer Report
2023-11-09 English
Director Declaration
Board/Management Information Classification · 1% confidence The document is titled 'Director Declaration' and announces a change in a director's external appointment (Philip Broadley, senior independent Non-Executive Director, appointed to the Board of Lancashire Holdings Limited). This type of announcement, detailing personal share transactions or external board appointments of directors/executives, falls under the category of Director's Dealing (DIRS) or potentially Board/Management Information (MANG). However, the specific nature of reporting director transactions/appointments is best captured by 'Director's Dealing' (DIRS) if it were a trade, but since it's an external appointment announcement, it strongly relates to management/director status changes. Given the options, 'Director's Dealing (DIRS)' is often used broadly for director-related disclosures, but 'Board/Management Information (MANG)' is a better fit for changes in director roles/appointments. Since the document explicitly states 'Director Declaration' and details a director's new role, MANG is the most precise fit among the provided definitions, as it covers 'Announcement of changes in the company's board of directors or senior management.' The presence of 'RNS Number' and the RNS footer confirms it is a regulatory announcement, but the content dictates the specific type.
2023-11-09 English
AGREEMENT WITH ECCOGENE FOR CLINICAL STAGE GLP-1RA
Foreign Filer Report
2023-11-09 English
9M AND Q3 2023 RESULTS
Foreign Filer Report
2023-11-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.